Terms: = Liver cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Treatment
189 results:
1. Esculin induces endoplasmic reticulum stress and drives apoptosis and ferroptosis in colorectal cancer via PERK regulating eIF2α/CHOP and nrf2/HO-1 cascades.
Ji X; Chen Z; Lin W; Wu Q; Wu Y; Hong Y; Tong H; Wang C; Zhang Y
J Ethnopharmacol; 2024 Jun; 328():118139. PubMed ID: 38561058
[TBL] [Abstract] [Full Text] [Related]
2. Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo.
Gong G; Wan Y; Liu Y; Zhang Z; Zheng Y
Int Immunopharmacol; 2024 May; 132():111959. PubMed ID: 38554442
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptomic screening of novel targets of sericin in human hepatocellular carcinoma cells.
Jantaravinid J; Tirawanchai N; Ampawong S; Kengkoom K; Somkasetrin A; Nakhonsri V; Aramwit P
Sci Rep; 2024 Mar; 14(1):5455. PubMed ID: 38443583
[TBL] [Abstract] [Full Text] [Related]
4. APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy.
Du Y; Zhou Y; Yan X; Pan F; He L; Guo Z; Hu Z
Cell Death Differ; 2024 Apr; 31(4):431-446. PubMed ID: 38418695
[TBL] [Abstract] [Full Text] [Related]
5. A nrf2 Regulated and the Immunosuppressive Microenvironment Reversed Nanoplatform for Cholangiocarcinoma Photodynamic-Gas Therapy.
Wang W; Gao Y; Xu J; Zou T; Yang B; Hu S; Cheng X; Xia Y; Zheng Q
Adv Sci (Weinh); 2024 Apr; 11(14):e2307143. PubMed ID: 38308097
[TBL] [Abstract] [Full Text] [Related]
6. Distinct mechanisms by which Nrf1 and nrf2 as drug targets contribute to the anticancer efficacy of cisplatin on hepatoma cells.
Wufuer R; Liu K; Feng J; Wang M; Hu S; Chen F; Lin S; Zhang Y
Free Radic Biol Med; 2024 Mar; 213():488-511. PubMed ID: 38278308
[TBL] [Abstract] [Full Text] [Related]
7. nrf2 mutation enhances the immune escape of hepatocellular carcinoma by reducing STING activation.
Li C; Liang G; Yan K; Wang Y
Biochem Biophys Res Commun; 2024 Feb; 698():149536. PubMed ID: 38271834
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
9. Interplay of oxidative stress, cellular communication and signaling pathways in cancer.
Iqbal MJ; Kabeer A; Abbas Z; Siddiqui HA; Calina D; Sharifi-Rad J; Cho WC
Cell Commun Signal; 2024 Jan; 22(1):7. PubMed ID: 38167159
[TBL] [Abstract] [Full Text] [Related]
10. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y
J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099
[TBL] [Abstract] [Full Text] [Related]
11. From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma.
Wang Z; Zhou C; Zhang Y; Tian X; Wang H; Wu J; Jiang S
Biomed Pharmacother; 2024 Jan; 170():116074. PubMed ID: 38147732
[TBL] [Abstract] [Full Text] [Related]
12. Impact of amino acid substitutions in hepatitis C virus core region on the severe oxidative stress.
Chida T; Watanabe S; Ohta K; Noritake H; Ito M; Suzuki T; Suda T; Kawata K
Free Radic Biol Med; 2024 Feb; 212():199-206. PubMed ID: 38103659
[TBL] [Abstract] [Full Text] [Related]
13. Loss of Nrf1 rather than nrf2 leads to inflammatory accumulation of lipids and reactive oxygen species in human hepatoma cells, which is alleviated by 2-bromopalmitate.
Deng R; Zheng Z; Hu S; Wang M; Feng J; Mattjus P; Zhang Z; Zhang Y
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119644. PubMed ID: 37996059
[TBL] [Abstract] [Full Text] [Related]
14. A state-of-the-art review on the nrf2 in Hepatitis virus-associated liver cancer.
Kalantari L; Ghotbabadi ZR; Gholipour A; Ehymayed HM; Najafiyan B; Amirlou P; Yasamineh S; Gholizadeh O; Emtiazi N
Cell Commun Signal; 2023 Nov; 21(1):318. PubMed ID: 37946175
[TBL] [Abstract] [Full Text] [Related]
15. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via nrf2/HO-1/GPX4 axis.
Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
[TBL] [Abstract] [Full Text] [Related]
16. Investigation of the effects of catharanthine and Q10 on nrf2 and its association with MMP-9, MRP1, and Bcl-2 and apoptosis in a model of hepatocellular carcinoma.
Heidari-Kalvani N; Alizadeh-Fanalou S; Yarahmadi S; Fallah S; Alipourfard I; Farahmandian N; Barjesteh F; Bahreini E
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2507-2522. PubMed ID: 37855932
[TBL] [Abstract] [Full Text] [Related]
17. Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.
Ouyang G; Wu Z; Liu Z; Pan G; Wang Y; Liu J; Guo J; Liu T; Huang G; Zeng Y; Wei Z; He S; Yuan G
Front Immunol; 2023; 14():1251750. PubMed ID: 37822923
[TBL] [Abstract] [Full Text] [Related]
18. Metabolic reprogramming in nrf2-driven proliferation of normal rat hepatocytes.
Kowalik MA; Taguchi K; Serra M; Caddeo A; Puliga E; Bacci M; Koshiba S; Inoue J; Hishinuma E; Morandi A; Giordano S; Perra A; Yamamoto M; Columbano A
Hepatology; 2024 Apr; 79(4):829-843. PubMed ID: 37603610
[TBL] [Abstract] [Full Text] [Related]
19. Unlocking the Potential: Novel NSAIDs Hybrids Unleash Chemopreventive Power toward liver cancer Cells through nrf2, NF-κB, and MAPK Signaling Pathways.
Narożna M; Krajka-Kuźniak V; Bednarczyk-Cwynar B; Baer-Dubowska W
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570726
[TBL] [Abstract] [Full Text] [Related]
20. [Preliminary study of PPARA regulate the ferroptosis of hepatocellular carcinoma to prevent disease deterioration].
Cai JJ; Liang MT; Li WQ; Zhang WY; Li X; Sun ZH
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jul; 57(7):1068-1074. PubMed ID: 37482742
[TBL] [Abstract] [Full Text] [Related]
[Next]
